Denise Grady, The New York Times Published: 10 Apr 2021 02:19 AM BdST Updated: 10 Apr 2021 02:23 AM BdST An undated graphic shows the imagining response of cells exposed to the AstraZeneca coronavirus disease (COVID-19) vaccine producing coronavirus native-like protein spikes. University of Southampton/via REUTERS A nurse fills a syringe with a dose of the AstraZeneca vaccine against the coronavirus disease (COVID-19) in Belgrade, Serbia, March 25, 2021. Reuters A vial with the AstraZeneca s coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. Reuters
Two reports published Friday in a leading medical journal help to explain how AstraZeneca’s COVID vaccine can, in rare cases, cause serious and sometimes fatal blood clots.
U.K. says under-30s should get a non-AstraZeneca option; E.U. finds a âpossible linkâ to rare clots.
Video
-0:00
E.U., U.K. Find Possible Rare Blood Clot Link to AstraZeneca Vaccine
Regulators in Britain and the European Union both said on Wednesday that blood clots were a possible rare side effect of the AstraZeneca Covid-19 vaccine. Britain said it would offer alternative vaccines for adults under 30.
âFirst of all, I want to start by stating that our safety committee, the Pharmacovigilance and Risk Assessment Committee of the European Medicines Agency, has confirmed that the benefits of the AstraZeneca vaccine in preventing Covid-19 overall outweigh the risks of side effects. The PRAC, after a very in-depth analysis, has concluded that the reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine.â âOur review has reinforced that the risk of this rare suspected